Confluent, Inc.

The stock is in a constructive multi-month recovery, holding near its 52-week high of 31 after a deep prior drawdown to 15.64. It remains above the 200-day moving average at 24.97 and slightly above the 50-day at 30.58, signaling a bullish longer-term regime rather than a broken trend.

Street sentiment is cautious-to-neutral: the consensus is Hold with 18 Buys, 19 Holds, and 1 Sell, while the average target sits at 31, essentially matching the current trading area. Recent action has skewed negative, with a cluster of downgrades from Bernstein, Citi, UBS, RBC, Deutsche Bank, and others, suggesting enthusiasm has cooled.

The earnings pattern is still solid, with Confluent beating EPS in 7 of the last 8 quarters. Next-year EPS is modeled at 0.6506 versus a TTM loss of 0.86, so shareholders should watch whether revenue growth and margin discipline keep the path toward profitability intact.

Recent insider activity is heavily negative, but the pattern is dominated by D-Return transactions rather than clear discretionary trading. The CEO, CFO, CAO, and a director all reported large sales, so the setup argues for caution around insider sentiment even if some of the activity reflects award-related mechanics.

Gross margin is strong at 74.3%, but profitability remains weak with operating margin at -27.5% and net margin at -25.3%. Revenue is still growing 20.5% year over year, and the balance sheet is solid with $2.05 billion of cash versus $1.11 billion of debt, leaving $948.6 million of net cash.

Confluent stands out on growth and gross margin versus many software peers, but it still trails on earnings quality because operating losses remain wide. The valuation picture is not cheap on current earnings, with a negative P/E and a target consensus of 31 that leaves limited upside from here.